Resources

Selected
  • COVID-19
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

1589 results found

2023 ∙ Guo, K. Ni, P. Chang, S. Jin, Y. Duan, G. Zhang, R.

Effectiveness of mRNA vaccine against Omicron-related infections in the real world: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Song, S. Madewell, Z. J. Liu, M. Longini, I. M. Yang, Y.

Effectiveness of SARS-CoV-2 vaccines against Omicron infection and severe events: a systematic review and meta-analysis of test-negative design studies

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ebrahim, S. Blose, N. Gloeck, N. Hohlfeld, A. Balakrishna, Y. Muloiwa, R. Gray, A. Parrish, A. Cohen, K. Lancaster, R. Kredo, T.

Effectiveness of the BNT162b2 vaccine in preventing morbidity and mortality associated with COVID-19 in children aged 5 to 11 years: A systematic review and meta-analysis

  • Children
  • Adolescents
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Paul, P. El-Naas, A. Hamad, O. Salameh, M. A. Mhaimeed, N. Laswi, I. Abdelati, A. A. AlAnni, J. Khanjar, B. Al-Ali, D. Pillai, K. V. Elshafeey, A. Alroobi, H. Burney, Z. Mhaimeed, O. Bhatti, M. Sinha, P. Almasri, M. Aly, A. Bshesh, K. Chamseddine, R. Khalil, O. D'Souza, A. Shree, T. Mhaimeed, N. Yagan, L. Zakaria, D.

Effectiveness of the pre-Omicron COVID-19 vaccines against Omicron in reducing infection, hospitalization, severity, and mortality compared to Delta and other variants: A systematic review

  • All age groups
  • COVID-19
  • Administration
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Hausinger, R. I. Bachmann, Q. Crone-Rawe, T. Hannane, N. Monsef, I. Haller, B. Heemann, U. Skoetz, N. Kreuzberger, N. Schmaderer, C.

Effectiveness, Immunogenicity and Harms of Additional SARS-CoV-2 Vaccine Doses in Kidney Transplant Recipients: A Systematic Review

  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Edele Santos, D. Colonetti, T. Rodrigues Uggioni, M. L. Rech, P. Marcelino Baptista, M. Medeiros, L. R. Grande, A. J. Rosa, M. I.

Effects of COVID-19 or vaccines for SARS-COV-2 on sperm parameters: A systematic review and meta-analysis

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2023 ∙ Rahmati, M. Yon, D. K. Lee, S. W. Butler, L. Koyanagi, A. Jacob, L. Shin, J. I. Smith, L.

Effects of COVID-19 vaccination during pregnancy on SARS-CoV-2 infection and maternal and neonatal outcomes: A systematic review and meta-analysis

  • Newborn
  • Pregnant women
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Moderate
2023 ∙ Li, G. Zhang, R. Song, B. Wang, C. Shen, Q. He, X. Cao, Y.

Effects of SARS-CoV-2 Vaccines on Sperm Quality: Systematic Review

  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Law, M. Ho, S. S. H. Tsang, G. K. C. Ho, C. M. Y. Kwan, C. M. Yan, V. K. C. Yiu, H. H. E. Lai, F. T. T. Wong, I. C. K. Chan, E. W. Y.

Efficacy and effectiveness of inactivated vaccines against symptomatic COVID-19, severe COVID-19, and COVID-19 clinical outcomes in the general population: a systematic review and meta-analysis

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2023 ∙ Kuniduzi, Y. Chen, B. Zeng, J. Sun, X. Chen, T. Qian, X. Wang, J. Liang, F. Abuduxukuer, R. Yusufu, M. Xu, S. Zhang, X.

Efficacy and safety of a fourth dose of the COVID-19 vaccine in kidney transplant recipients: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...